“…The similarity of the proposed mold spore dose dependencies for abatement of flu and COVID-19 suggests a shared receptor. Although much attention has been given to angiotensin-converting enzyme 2 (ACE-2) and its role in COVID-19 [ 12 , 13 ], there are compelling reasons to believe TLR4, which binds the SARS-CoV-2 spike protein with greater affinity than does ACE-2 [ 49 ], is also operative: 1) TLR4 is implicated in the inflammatory response triggered by sharply seasonal respiratory viruses [ 16 , 17 , 18 ], 2) TLR4 has a significant role in innate defense against multiple species of fungi [ 19 , 20 ] and polymorphisms in TLR4 are associated with invasive fungal disease [ 50 , 51 ], 3) COVID-19 prognosis correlates with radiographic involvement of alveolar spaces [ 21 , 22 ], the epithelial surfaces of which are poor in ACE-2 [ 52 , 53 ] but rich in TLR4 [ 23 ], (4) inflammation of the sort associated with acute lung injury is mediated by TLR4 [ 14 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 ], (5) age-dependent hyper-responsiveness of TLR4 [ 24 ], especially in the context of interactions with TLR5 [ 25 , 26 ], can account for the age-dependent severity of COVID-19 and (6) fibrino(gen) D-dimers are markedly elevated in persons with severe COVID-19 [ 28 ]. That TLR4 may be involved in the processing of bioaerosols is also expected on phylogenetic grounds: the receptor has been retained by some fish that breathe air but lost by those that do not [ 63 ], and the eponymous Toll receptor controls the antifungal response of Drosophila [ 64 ].…”